FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Clears ClaroNav Surgical Navigation Device

FDA clears a ClaroNav 510(K) for NaviENT, a computer-assisted surgical navigation system for surgical procedures inside a patients skull.

Federal Register

FDA Meeting on Antimicrobial Resistance Monitoring

Federal Register notice: FDA announces a 10/24-25 public meeting entitled 2017 Scientific Meeting of the National Antimicrobial Resistance Monitoring ...

Federal Register

Workshop on Pediatric Drug Development for Heart Failure

Federal Register notice: FDA announces a 10/27 public workshop entitled FDA-University of Maryland CERSI Drug Development in Pediatric Heart Failure: ...

Federal Register

FDA Panel to Review Intraocular Pressure Drug

Federal Register notice: FDAs Dermatologic and Ophthalmic Drugs Advisory Committee meets 10/13 to review intraocular pressure drug.

Human Drugs

FDA OKs 98% of Individual Expanded Access Requests

Four FDAers analyze the agencys response to individual drug expanded-access requests over a four-year period and find that 98% were allowed to proceed...

Human Drugs

Diverse Views on Waxman-Hatch Balance

Stakeholders offer FDA a variety of perspectives on how well the Waxman-Hatch amendments balance innovation and access.

Human Drugs

FDA Backs Use of Opioid Addiction Drugs Despite Risks

FDA says that opioid addiction medications buprenorphine and methadone should continue to be given to patients taking benzodiazepines or other drugs d...

Human Drugs

FDA Panel to Review Resubmitted Testosterone NDA

FDA tells Lipocine that the agencys Bone, Reproductive and Urologic Drugs Advisory Committee plans to discuss the companys NDA for Tlando, an oral tes...

Medical Devices

FDA Clears Stryker 3D Printed Cervical Cage

FDA clears a Stryker Spine division 510(k) for its Tritanium C Anterior Cervical Cage, a 3D-printed interbody fusion cage intended for use in the cerv...

Human Drugs

Pfizer Says J&J Illegally Blocking Remicade Competition

Pfizer sues Johnson & Johnson claiming antitrust violations in J&J efforts to prevent purchasers and insurers from using Pfizers Inflectra, an approve...